Clinical Trial Doctors

Home » Clinical Trial Doctors

Principal Investigators

Dr. Bressler is a Clinical Assistant Professor of Medicine, in the Division of Gastroenterology at the University of British Columbia’s Department of Medicine.  Dr. Bressler received his MD from the University of British Columbia and completed his residency in internal medicine and gastroenterology at the University of Toronto.  He received an MS in Epidemiology from the Harvard Public School of Health and completed an advanced fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital, Harvard Medical School.  Dr. Bressler is a recognized expert in inflammatory bowel disease.  His research interests include population based studies, classic clinical epidemiology studies and clinical trials in inflammatory bowel disease.  He is an invited reviewer for many medical journals including Gastroenterology, Clinical Gastroenterology and Hepatology, and American Journal of Gastroenterology.

Dr. Marshall is an Associate Professor of Medicine at McMaster University and an active consultant gastroenterologist at Hamilton Health Sciences. He completed his B.A. and M.D. at Queen’s University, and then undertook his residency training and M.Sc. in Clinical Epidemiology & Biostatistics at McMaster University. There he is now a Full Member of the Farncombe Family Digestive Health Research Institute, Director of the Training Program in Adult Gastroenterology, and Head of Clinical Research for the Division of Gastroenterology.

His publications include over 90 academic papers and book chapters and 100 abstracts. He serves as an Associate Editor of the ACP Journal Club and Evidence-Based Medicine, Co-Editor of the Cochrane Collaboration IBD Review Group and a Member of Editorial Boards for the Canadian Journal of Gastroenterology and the World Journal of Gastroenterology.

Dr. Marshall has held a Clinician Scientist Award from the Canadian Institutes of Health Research (CIHR) and has received peer-reviewed research funding from several agencies including CIHR and the Crohn’s and Colitis Foundation of Canada. Recent honours include the Canadian Association of Gastroenterology (CAG) Young Investigator Award (2008), Fellowship in the American Gastroenterological Association (2007), the CAG Young Educator Award (2006) and the American College of Gastroenterology Governor’s Award for Excellence in Clinical Research (2003).

Dr. Marshall’s clinical and research interests include inflammatory bowel disease, post-infectious irritable bowel syndrome, gastrointestinal bleeding, clinical trials, clinical epidemiology, health outcomes and health economics.

Medical Monitors

Dr. Sutcliffe is the Chief Medical Officer (CMO) at Qu Biologics Inc. He is a distinguished clinician, scientist and leading visionary in cancer control in Canada and internationally.  A graduate of St.  Bartholomew’s Hospital, London, England, Dr. Sutcliffe’s training encompassed internal medicine, scientific research, medical and radiation oncology in the UK, South Africa, US and Canada. Dr. Sutcliffe has been President and CEO of the Ontario Cancer Institute and Princess Margaret Hospital (1994-96) and the BC Cancer Agency (2000-09).  Dr. Sutcliffe is currently the President of the International Cancer Control Congress Association, President of Two Worlds Cancer Collaboration (the Canadian Branch of the International Network for Cancer Treatment and Research), and Board Chair, Institute for Health Systems Sustainability.  Dr. Sutcliffe was awarded the Queen Elizabeth 50th Jubilee Gold Medal in 2003 and the Terry Fox Award (of the B.C. Medical Association) in 2009 for his lifetime services to cancer control.